Scout | RFA-NS-23-007: HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant RFA-NS-23-007

HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)

Summary

This grant opportunity is designed to accelerate scientific advancements addressing the national opioid crisis by funding small businesses to develop improved pain management solutions. It supports projects aimed at creating new non-addictive pain medications, advanced pain-measuring devices, and innovative pain screening tools and models.

The purpose of this Funding Opportunity Announcement (FOA) aims to speed scientific solutions to stem the national opioid public health crisis by supporting the development of therapies and technologies directed at enhanced pain management through the Small Business Technology Transfer (STTR) pr…

Funding Source

Agency: National Institutes of Health

Sub-agency: National Institute of Neurological Disorders and Stroke

Program: SBIR

Dates

Opportunity Released: September 15, 2022

Open for Submission: September 15, 2022

Submission Deadline: April 4, 2025

Application Window Closes: April 4, 2025

Supporting links

National Institutes of Health

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers